Rapid initiation of quetiapine well tolerated as compared with the conventional initiation regimen in patients with schizophrenia or schizoaffective disorders

Bibliographic Details
Title: Rapid initiation of quetiapine well tolerated as compared with the conventional initiation regimen in patients with schizophrenia or schizoaffective disorders
Authors: Cheng-Cheng Hsiao, Kun-Po Chen, Chang-Jer Tsai, Liang-Jen Wang, Chih-Ken Chen, Shih-Ku Lin
Source: Kaohsiung Journal of Medical Sciences, Vol 27, Iss 11, Pp 508-513 (2011)
Publisher Information: Wiley, 2011.
Publication Year: 2011
Collection: LCC:Medicine (General)
Subject Terms: Efficacy, Higher dose, Quetiapine, Rapid initiation, Tolerability, Medicine (General), R5-920
More Details: A 2-week, randomized, parallel-group open trial was designed to evaluate the safety and tolerability of a rapid initiation regimen with a higher dose of quetiapine (up to 800 mg/d by Day 4) than that used in the conventional initiation regimen of quetiapine (up to 400 mg/d by Day 5) in patients with schizophrenia or schizoaffective disorders. Forty patients were recruited and randomly (3:1) assigned to either the group with rapid initiation of quetiapine or the group with conventional initiation. At the end of the investigation, the difference between the groups in the incidence of adverse events was not significant; a significant drop in the Barnes Akathisia Rating Scale and Simpson-Angus Scale scores was observed only in the group with the rapid initiation regimen. The groups did not differ in terms of improvement on the Clinical Global Impression—Severity of Illness and Positive and Negative Syndrome Scale at the end of the study. The results of our 2-week study suggest that rapid initiation with a higher dose of quetiapine (up to 800 mg/d by Day 4) is well tolerated in patients with schizophrenia or schizoaffective disorders and does not compromise efficacy relative to the conventional initiation.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1607-551X
Relation: http://www.sciencedirect.com/science/article/pii/S1607551X11001355; https://doaj.org/toc/1607-551X
DOI: 10.1016/j.kjms.2011.06.014
Access URL: https://doaj.org/article/b4ccfadabb4d418f8cca544070c52ed9
Accession Number: edsdoj.b4ccfadabb4d418f8cca544070c52ed9
Database: Directory of Open Access Journals
More Details
ISSN:1607551X
DOI:10.1016/j.kjms.2011.06.014
Published in:Kaohsiung Journal of Medical Sciences
Language:English